122 related articles for article (PubMed ID: 10839771)
1. Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia.
Kinoshita M; Oikawa S; Hayasaka K; Sekikawa A; Nagashima T; Toyota T; Miyazawa T
Clin Chem; 2000 Jun; 46(6 Pt 1):822-8. PubMed ID: 10839771
[TBL] [Abstract][Full Text] [Related]
2. Plasma phosphatidylcholine hydroperoxide as a new marker of oxidative stress in alcoholic patients.
Adachi J; Matsushita S; Yoshioka N; Funae R; Fujita T; Higuchi S; Ueno Y
J Lipid Res; 2004 May; 45(5):967-71. PubMed ID: 14754913
[TBL] [Abstract][Full Text] [Related]
3. High phosphatidylcholine hydroperoxide level in plasma of guinea pigs with low and excess supplementation of ascorbic acid.
Kinoshita M; Fujimoto K; Miyazawa T
J Nutr Sci Vitaminol (Tokyo); 1996 Feb; 42(1):35-46. PubMed ID: 8708820
[TBL] [Abstract][Full Text] [Related]
4. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay.
Miyazawa T
Free Radic Biol Med; 1989; 7(2):209-17. PubMed ID: 2806945
[TBL] [Abstract][Full Text] [Related]
5. Determination of lipid hydroperoxides in low density lipoprotein from human plasma using high performance liquid chromatography with chemiluminescence detection.
Miyazawa T; Fujimoto K; Oikawa S
Biomed Chromatogr; 1990 May; 4(3):131-4. PubMed ID: 2383696
[TBL] [Abstract][Full Text] [Related]
6. Effects of anti-free radical interventions on phosphatidylcholine hydroperoxide in plasma after ischemia-reperfusion in the liver of rats.
Takayama F; Egashira T; Kudo Y; Yamanaka Y
Biochem Pharmacol; 1993 Nov; 46(10):1749-57. PubMed ID: 8250960
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylcholine hydroperoxide levels in human plasma are lower than previously reported.
Adachi J; Yoshioka N; Funae R; Nagasaki Y; Naito T; Ueno Y
Lipids; 2004 Sep; 39(9):891-6. PubMed ID: 15669765
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of phosphatydilcholine-hydroperoxide in dialysis patients with diabetic nephropathy.
Sanaka T; Takahashi C; Sanaka M; Higuchi C; Shinobe M; Hayasaka Y; Miyazawa T; Ishikawa S; Nihei H; Omori Y
Clin Nephrol; 1995 Nov; 44 Suppl 1():S33-7. PubMed ID: 8608660
[TBL] [Abstract][Full Text] [Related]
9. Presence of phosphatidylcholine hydroperoxide in human plasma.
Miyazawa T; Yasuda K; Fujimoto K; Kaneda T
J Biochem; 1988 May; 103(5):744-6. PubMed ID: 2846518
[TBL] [Abstract][Full Text] [Related]
10. Hemodialysis does not influence the peroxidative state already present in uremia.
Hirayama A; Nagase S; Gotoh M; Takemura K; Tomida C; Ueda A; Aoyagi K; Terao J; Koyama A
Nephron; 2000 Dec; 86(4):436-40. PubMed ID: 11124591
[TBL] [Abstract][Full Text] [Related]
11. Determination of Phosphatidylcholine Hydroperoxide (PCOOH) as a Marker of Membrane Lipid Peroxidation.
Nakagawa K; Kato S; Miyazawa T
J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S78-80. PubMed ID: 26598897
[TBL] [Abstract][Full Text] [Related]
12. Hyperlipidemia in coronary heart disease. 3. Evaluation of lipoprotein phenotypes of 156 genetically defined survivors of myocardial infarction.
Hazzard WR; Goldstein JL; Schrott MG; Motulsky AG; Bierman EL
J Clin Invest; 1973 Jul; 52(7):1569-77. PubMed ID: 4352458
[TBL] [Abstract][Full Text] [Related]
13. Direct separation of the diastereomers of phosphatidylcholine hydroperoxide bearing 13-hydroperoxy-9Z,11E-octadecadienoic acid using chiral stationary phase high-performance liquid chromatography.
Ito J; Nakagawa K; Kato S; Hirokawa T; Kuwahara S; Nagai T; Miyazawa T
J Chromatogr A; 2015 Mar; 1386():53-61. PubMed ID: 25687457
[TBL] [Abstract][Full Text] [Related]
14. [HDL2 and HDL3 cholesterol in men and women in different forms of hyperlipidemia without arterial involvement].
Rozensztajn L; Loeper J; Goy J; Bedu O
Pathol Biol (Paris); 1986 Nov; 34(9):988-92. PubMed ID: 3543817
[TBL] [Abstract][Full Text] [Related]
15. Fructose ingestion enhances atherosclerosis and deposition of advanced glycated end-products in cholesterol-fed rabbits.
Tokita Y; Hirayama Y; Sekikawa A; Kotake H; Toyota T; Miyazawa T; Sawai T; Oikawa S
J Atheroscler Thromb; 2005; 12(5):260-7. PubMed ID: 16205022
[TBL] [Abstract][Full Text] [Related]
16. Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients.
Nagashima T; Oikawa S; Hirayama Y; Tokita Y; Sekikawa A; Ishigaki Y; Yamada R; Miyazawa T
Diabetes Res Clin Pract; 2002 Apr; 56(1):19-25. PubMed ID: 11879717
[TBL] [Abstract][Full Text] [Related]
17. An improved HPLC assay for phosphatidylcholine hydroperoxides (PCOOH) in human plasma with synthetic PCOOH as internal standard.
Hui SP; Chiba H; Sakurai T; Asakawa C; Nagasaka H; Murai T; Ide H; Kurosawa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):158-63. PubMed ID: 17627906
[TBL] [Abstract][Full Text] [Related]
18. Elimination of plasma phosphatidylcholine hydroperoxide by a seleno-organic compound, Ebselen.
Miyazawa T; Suzuki T; Fujimoto K; Kinoshita M
J Biochem; 1993 Oct; 114(4):588-91. PubMed ID: 8276773
[TBL] [Abstract][Full Text] [Related]
19. The multiple hydroperoxides of choline phospholipids occurring in plasma after ischemia-reperfusion in rat liver.
Takayama F; Egashira T; Yamanaka Y
J Toxicol Sci; 1994 May; 19(2):97-106. PubMed ID: 8072044
[TBL] [Abstract][Full Text] [Related]
20. Recognition of familial dyslipidemias in 5-year-old children using the lipid phenotypes of parents. The STRIP project.
Lapinleimu J; Nuotio IO; Lapinleimu H; Simell OG; Rask-Nissila L; Viikari JS
Atherosclerosis; 2002 Feb; 160(2):417-23. PubMed ID: 11849666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
